Functional Characterization of Candida albicans ABC Transporter Cdr1p

Eukaryotic Cell

Volumn 2, Issue 6, 2003, Pages 1361-1375

  Shukla, Suneet ^a   Saini, Preeti ^a   Smriti, ^a,c   Jha, Sudhakar ^a   Ambudkar, Suresh V ^b   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; CYCLOHEXIMIDE; FLUORESCENT DYE; FUNGAL PROTEIN; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; PHOTOPROTEIN; PROTEIN SYNTHESIS INHIBITOR; RHODAMINE; RHODAMINE 6G;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CANDIDA ALBICANS; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; DRUG EFFECT; ENZYME SPECIFICITY; GENETIC VARIABILITY; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS;

ADENOSINE TRIPHOSPHATASES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODIES, MONOCLONAL; ATP-BINDING CASSETTE TRANSPORTERS; CANDIDA ALBICANS; CONSERVED SEQUENCE; CYCLOHEXIMIDE; DRUG RESISTANCE, MULTIPLE, FUNGAL; FLUORESCENT DYES; FUNGAL PROTEINS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; PROTEIN SYNTHESIS INHIBITORS; RHODAMINES; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY; VARIATION (GENETICS);

CANDIDA; CANDIDA ALBICANS; MAMMALIA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0347694571     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.2.6.1361-1375.2003     Document Type: Article

References (48)

1. Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40:2835-2841.
2. Altherr, M. R., L. A. Quinn, C. I. Kado, and R. L. Rodroguez. 1983. Transformation and storage of competent yeast cells. Genet. Eng. Eukaryot. 1983: 33-36.
3. Ambudkar, S. V., S. Dey, C. A. Hrycyna, M. Ramachandran, I. Pastan, and M. M. Gottesman. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:361-398.
4. Booth, C. L., L. Pulaski, M. M. Gottesman, and I. Pastan. 2000. Analysis of the properties of the N-terminal nucleotide-binding domain of human P-glycoprotein. Biochemistry 39:5518-5526.
5. Brown, C. R., and W. J. Welch. 1996. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones 1:109-115.
6. Bruggemann, E. P., U. A. Germann, M. M. Gottesman, and I. Pastan. 1989. Two different regions of phosphoglycoprotein are photoaffinity-labeled by azidopine. J. Biol. Chem. 264:15483-15488.
7. Chen, G., G. E. Duran, K. A. Steger, N. J. Lacayo, J. P. Jaffrezou, C. Dumontet, and B. I. Sikic. 1997. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J. Biol. Chem. 272:5974-5982.
8. Cheng, S. H., R. J. Gregory, J. Marshall, S. Paul, D. W. Souza, G. A. White, C. R. O'Riordan, and A. E. Smith. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63:827-834.
9. Decottignies, A., A. M. Grant, J. W. Nichols, H. De Wet, D. B. McIntosh, and A. Goffeau. 1998. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273:12612-12622.
10. Decottignies, A., M. Kolaczkowski, E. Balzi, and A. Goffeau. 1994. Solubilisation and characterisation of the overexpressed PDR5 multidrug resistance nucleotide triphosphatase of yeast. J. Biol. Chem. 269:12797-12803.
11. Denning, G. M., M. P. Anderson, J. F. Amara, J. Marshall, A. E. Smith, and M. J. Welsh. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761-764.
12. Dey, S., M. Ramachandran, I. Pastan, M. M. Gottesman, and S. V. Ambudkar. 1998. Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding. Methods Enzymol. 292:318-328.
13. Dogra, S., S. Krishnamurthy, V. Gupta, B. L. Dixit, C. M. Gupta, D. Sanglard, and R. Prasad. 1999. Asymmetric distribution of phosphatidylethanolamine in C. albicans: possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast 15:111-121.
14. Golin, J., S. V. Ambudkar, M. M. Gottesman, A. Habib, J. Sczepanski, W. Ziccardi, and L. May. 2003. Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J Biol. Chem. 278:5963-5969.
15. Gottesman, M. M., C. A. Hrycyna, P. V. Schoenlein, U. A. Germann, and I. Pastan. 1995. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29:607-649.
16. Greenberger, L. M. 1993. Major photoaffinity drug labeling sites for iodoaryl azidoprasin in P-glycoprotein are within, or immediately C-terminal to transmembrane domains 6 and 12. J. Biol. Chem. 268:11417-11425.
17. Greenberger, L. M., C. J. Lisanti, J. T. Silva, and S. B. Horwitz. 1991. Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b. J. Biol. Chem. 266:20744-20751.
18. Higgins, C. F. 1993. The ABC transporter channel superfamily - an overview. Semin. Cell Biol. 4:1-5.
19. Hoffman, C. S., and F. Winston. 1987. A ten minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267-272.
20. Kajiji, S., F. Talbot, K. Grizzuti, V. Van Dyke-Phillips, M. Agresti, A. R. Safa, and P. Gros. 1993. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site. Biochemistry 32:4185-4194.
21. Katzmann, D. J., E. A. Epping, and W. S. Moye-Rowley. 1999. Mutational disruption of plasma membrane trafficking of Saccharomyces cerevisiae Yor1p, a homologue of mammalian multidrug resistance protein. Mol. Cell. Biol. 19:2998-3009.
22. Keppler, D., Y. Cui, J. Konig, I. Leier, and A. Nies. 1999. Export pumps for anionic conjugates encoded by MRP genes. Adv. Enzyme Regul. 39:237-246.
23. Krishnamurthy, S., U. Chatterjee, V. Gupta, R. Prasad, P. Das, P. Snehlata, S. E. Hasnain, and R. Prasad. 1998. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system. Yeast 14:535-550.
24. Krishnamurthy, S., V. Gupta, P. Snehlata, and R. Prasad. 1998. Characterisation of human steroid hormone transport mediated by Cdr1p, multidrug transporter of Candida albicans, belonging to the ATP binding cassette superfamily. FEMS Microbiol. Lett. 158:69-74.
25. Litman, T., T. E. Druley, W. D. Stein, and S. E. Bates. 2001. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol. Life Sci. 58:931-959.
26. Loo, T. W., and D. M. Clarke. 1993. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. J. Biol. Chem. 268:19965-19972.
27. Loo, T. W., and D. M. Clarke. 1994. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. Biochemistry 33:14049-14057.
28. Loo, T. W., and D. M. Clarke. 1997. Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J. Biol. Chem. 272:709-712.
29. Maesaki, S., P. Marichal, H. V. Bossche, D. Sanglard, and S. Kohno. 1999. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 44:27-31.
30. +-ATPase from Candida albicans. J. Bacteriol. 173:6826-6836.
31. Morschhauser, J., S. Michel, and J. Hacker. 1998. Expression of a chromosomally integrated, single-copy GFP gene in Candida albicans, and its use as a reporter of gene regulation. Mol. Gen. Genet. 257:420.
32. Mukhopadhyay, K., A. Kohli, and R. Prasad. 2002. Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 46:3695-3705.
33. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2002. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374.
34. Odds, F. C. 1988. Candida and candidosis: a review and bibliography. Ballière Tindall, London, United Kingdom.
35. Pao, S. S., I. T. Paulsen, and M. H. Saier, Jr. 1998. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62:1-34.
36. Prasad, R., P. D. Worgifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterisation of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
37. Safa, A. R. 1988. Photoaffinity labelling of the multidrug-resistance- related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl. Acad. Sci. USA 85:7187-7191.
38. Sanglard, D., F. Ischer, D. Calabrese, P. A. Majcherczyk, and J. Bille. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765.
39. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305.
40. Sanglard, D., F. Ischer, M. Monod, and J. Bille, 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterisation of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
41. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
42. Sarkadi, B., E. M. Price, R. C. Boucher, U. A. Germann, and G. A. Scarborough. 1992. Expression of the human multidrug resistant cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267:4854-4858.
43. Sato, S., C. L. Ward, M. E. Krouse, J. J. Wine, and R. R. Kopito. 1996. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271:635-638.
44. Sauna, Z. E., and S. V. Ambudkar. 2000. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc. Natl. Acad. Sci. USA 97:2515-2520.
45. Sauna, Z. E., and S. V. Ambudkar. 2001. Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. J. Biol. Chem. 276:11653-11661.
46. Schaffner, W., and C. Weissmann. 1973. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56:502-514.
47. Scherer, S., and D. A. Stevens. 1987. Application of DNA typing methods to epidemiology and taxonomy of Candida albicans. J. Clin. Microbiol. 25:675-679.
48. Walker, J. E., M. Sarsate, M. Runswick, and N. J. Gay. 1982. Distantly related sequences in the a- and b-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:945-951.